Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer
about
PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbetaAn essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cellsRecruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptorPolymorphism and domain variability of human killer cell inhibitory receptorsThe human natural killer cell immune synapseStructure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptorA human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cellsActivation of NK cells by an endocytosed receptor for soluble HLA-G.The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV InfectionsImproving the outcome of leukemia by natural killer cell-based immunotherapeutic strategiesCrystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoiresIdentification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donorsIL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyEnrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory studyDifferential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptorsCanonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family.CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72Cobalt-mediated dimerization of the human natural killer cell inhibitory receptor.Natural killer cells and mast cells from gp49B null mutant mice are functional.Self-association of an activating natural killer cell receptor, KIR2DS1KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infectionRe-educating natural killer cells.KIR/HLA interactions and pathogen immunityNatural killer cell responses to viral infection.New directions in natural killer cell-based immunotherapy of human cancer.Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretionNatural killer cells: role in local tumor growth and metastasisDonor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2AHLA-C and HIV-1: friends or foes?KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.Human herpesviridae methods of natural killer cell evasionMicroclusters of inhibitory killer immunoglobulin-like receptor signaling at natural killer cell immunological synapsesPeptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
P2860
Q22011205-D47CE247-E287-492C-B4B6-1DCF4EF70873Q24310297-4ED30320-7BC4-4CB1-BED6-70535281ACD0Q24318464-36232DDB-F4A9-4ABA-BDB7-F6C6E25010CCQ24329103-8EF33C7B-03E3-436B-8234-60565343E432Q24656137-C2C15C96-01E1-445D-977D-21287627B8B9Q24671977-8D25FDF5-6804-4F84-8F88-CD524F0E91F3Q24676716-57F6C8BE-4511-476C-ABCD-A3EBEB664705Q24813830-FC5C574B-38E7-4814-9314-DC39AD926EFFQ26742135-4F9EBD3C-66E3-4BC7-BEA7-ACB84F1F1862Q26768628-1FCE18C8-1A6E-49A5-8187-4C1F21ADA7EBQ26996660-F62704A3-E2B7-4064-A398-19138A5999C9Q27617783-45A5E1BB-537B-4E44-9772-CAD6749F7196Q28138946-E38223B5-DBD9-4C13-B3EC-E6A0336F9180Q28199747-C852110F-D795-4653-AB74-69CC7FDB11E2Q28477057-0F8E2F4A-75B0-472C-A8F6-BCF66FBCF249Q28740790-49A88F98-FAA1-448D-81DA-74F25E842B50Q28776435-3CF184BB-3D5E-4D23-9715-8B990A6EF340Q30252783-91A9B79F-A2C2-4CB5-A83B-3F673E727A06Q30657557-E61CF6A8-5C1E-42EE-AD38-985E1166DAA9Q33296978-73CFDD78-8127-47AE-A426-2FB4098E1862Q33902254-CB52BFB0-3B6B-4203-9FD0-8C5F2163AD3CQ33965755-A8138142-6433-4B84-9FF5-70E9A91C0B02Q34017545-EA08EB5E-47BE-4B91-ACA8-D383C505A4E0Q34055276-230D6263-343D-4DD8-B4A6-C42FD6AD6D4CQ34161487-8E085030-D5B4-4790-B677-3325A272339FQ35001169-EB126475-3547-4697-91BE-74B1F87C4EFAQ35082268-E020E8C7-3623-49D0-866E-F55C4BE7B9F9Q35093608-BA90025A-BFCF-4739-A6BE-8849ECA7C6DFQ35600095-4FF29313-E891-4F86-9C6D-97CECBE0C8BCQ35661770-F98BFF11-57D6-4F92-90EC-51550EEB45E5Q35848493-42046CA7-729F-4F55-BD8E-8A7BA8D37332Q35905953-D518F3B0-A3F6-476F-B0A8-D6BBCFEA81B3Q35921766-F0E17018-5F8B-44B5-80EE-B9F6A663268BQ36065870-8A5B9C00-A854-48DC-AB27-67E3339CDA57Q36066058-1AA23029-DCFA-435B-93AE-EFDCE44A8943Q36094774-0BF607BA-0823-42F0-A908-715972682A3EQ36102137-DEDC4A91-1711-4BD3-A061-2B29894C5B95Q36118221-F32F0D4E-D424-4197-8535-E6DE1D412C08Q36183939-61F26977-3CEF-4A8D-9B30-423114C8B06EQ36227213-B5C26797-8070-4C99-A2C3-0034FBDB2E6F
P2860
Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Killer cell inhibitory recepto ...... ing and by functional transfer
@ast
Killer cell inhibitory recepto ...... ing and by functional transfer
@en
Killer cell inhibitory recepto ...... ing and by functional transfer
@nl
type
label
Killer cell inhibitory recepto ...... ing and by functional transfer
@ast
Killer cell inhibitory recepto ...... ing and by functional transfer
@en
Killer cell inhibitory recepto ...... ing and by functional transfer
@nl
prefLabel
Killer cell inhibitory recepto ...... ing and by functional transfer
@ast
Killer cell inhibitory recepto ...... ing and by functional transfer
@en
Killer cell inhibitory recepto ...... ing and by functional transfer
@nl
P2093
P3181
P1433
P1476
Killer cell inhibitory recepto ...... ing and by functional transfer
@en
P2093
C C Winter
N Wagtmann
S Rajagopalan
P3181
P356
10.1016/1074-7613(95)90069-1
P407
P577
1995-12-01T00:00:00Z